PAM
PGNX
Panagora Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-17,512
| Closed | -$67K | – | 2717 |
|
|
2020
Q1 | $67K | Buy |
+17,512
| New | +$67K | ﹤0.01% | 1820 |
|
|
2018
Q1 | – | Sell |
-3,581
| Closed | -$21K | – | 2438 |
|
|
2017
Q4 | $21K | Hold |
3,581
| – | – | ﹤0.01% | 2168 |
|
|
2017
Q3 | $26K | Hold |
3,581
| – | – | ﹤0.01% | 2149 |
|
|
2017
Q2 | $24K | Hold |
3,581
| – | – | ﹤0.01% | 2227 |
|
|
2017
Q1 | $34K | Hold |
3,581
| – | – | ﹤0.01% | 2078 |
|
|
2016
Q4 | $31K | Sell |
3,581
-7,806
| -69% | -$67.6K | ﹤0.01% | 2157 |
|
|
2016
Q3 | $72K | Sell |
11,387
-21,528
| -65% | -$136K | ﹤0.01% | 2046 |
|
|
2016
Q2 | $139K | Hold |
32,915
| – | – | ﹤0.01% | 1810 |
|
|
2016
Q1 | $143K | Sell |
32,915
-169,573
| -84% | -$737K | ﹤0.01% | 1765 |
|
|
2015
Q4 | $1.24M | Buy |
202,488
+12,712
| +7% | +$77.9K | 0.01% | 976 |
|
|
2015
Q3 | $1.09M | Buy |
189,776
+44,049
| +30% | +$252K | 0.01% | 1001 |
|
|
2015
Q2 | $1.09M | Buy |
145,727
+134,152
| +1,159% | +$1M | 0.01% | 1056 |
|
|
2015
Q1 | $69K | Sell |
11,575
-3,611
| -24% | -$21.5K | ﹤0.01% | 2019 |
|
|
2014
Q4 | $115K | Hold |
15,186
| – | – | ﹤0.01% | 1822 |
|
|
2014
Q3 | $79K | Sell |
15,186
-6,660
| -30% | -$34.6K | ﹤0.01% | 1922 |
|
|
2014
Q2 | $94K | Hold |
21,846
| – | – | ﹤0.01% | 1948 |
|
|
2014
Q1 | $89K | Hold |
21,846
| – | – | ﹤0.01% | 1965 |
|
|
2013
Q4 | $116K | Hold |
21,846
| – | – | ﹤0.01% | 1814 |
|
|
2013
Q3 | $110K | Buy |
+21,846
| New | +$110K | ﹤0.01% | 1838 |
|